|
|
Volumn 191, Issue 4, 2014, Pages 889-890
|
|
Impact of statins on genitourinary cancer outcomes: The promise and the challenge
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
CHOLESTEROL;
MEVALONIC ACID;
CANCER GROWTH;
CANCER PREVENTION;
CANCER PROGNOSIS;
CANCER SCREENING;
CANCER STAGING;
CARDIOVASCULAR DISEASE;
EDITORIAL;
HUMAN;
PRIORITY JOURNAL;
RISK REDUCTION;
UROGENITAL TRACT CANCER;
CANCER MORTALITY;
CANCER SURVIVAL;
CARCINOGENESIS;
COMORBIDITY;
DISEASE ASSOCIATION;
DISEASE COURSE;
DOSE RESPONSE;
DRUG METABOLISM;
DRUG TOLERABILITY;
HYPERCHOLESTEROLEMIA;
INFLAMMATION;
KIDNEY CANCER;
KIDNEY TUMOR;
OBSERVATIONAL STUDY;
OUTCOME ASSESSMENT;
POST TREATMENT SURVIVAL;
PREVALENCE;
PROSTATE CANCER;
RECURRENCE FREE SURVIVAL;
RISK FACTOR;
SELECTION BIAS;
SMOKING;
STEROIDOGENESIS;
TESTIS CANCER;
TUMOR GROWTH;
CARCINOMA, RENAL CELL;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
KIDNEY NEOPLASMS;
MALE;
|
|
EID: 84898427869
PISSN: 00225347
EISSN: 15273792
Source Type: Journal
DOI: 10.1016/j.juro.2014.01.034 Document Type: Editorial |
|
Times cited : (2)
|
|
References (8)
|
